TrialJournal of translational medicine2019

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients.

Suwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.